How Hospices Can Work with ‘Payviders’

Why It Matters

Risk‑bearing payviders shift financial risk to hospices, making outcome‑based performance essential for revenue and market relevance.

Key Takeaways

• Payviders combine insurance and provider services, reshaping hospice contracts.
• Humana, UnitedHealth, and SCAN lead payvider expansion in hospice market.
• Integrated models demand outcome‑based metrics and tighter care coordination.
• Hospices must align operations with payer expectations to stay competitive.
• Risk‑bearing arrangements increase accountability for patient experience and quality.

Pulse Analysis

The term "payvider"—a hybrid of payer and provider—has moved from niche jargon to a defining feature of the U.S. health‑care landscape. Giants such as Humana, which runs the home‑care subsidiary Centerwell, and UnitedHealth Group, owner of LHC Group and Amedisys, illustrate how insurers are acquiring hospice and home‑health assets to control the entire care continuum. California‑based SCAN Group, originally a Medicare Advantage organization, has followed suit, adding a PACE program, primary‑care clinics and a homeless‑care network to its portfolio. This vertical integration promises smoother transitions for patients but forces hospices to renegotiate relationships that were once purely fee‑for‑service.

For hospices, the shift means more than a new billing partner; it requires a fundamental redesign of operations. Payvider contracts increasingly tie reimbursement to quality benchmarks, readmission rates and patient‑experience scores, turning financial risk into a shared responsibility. Successful models, such as Kaiser Permanente’s fully owned system, demonstrate how aligned incentives can drive coordinated care pathways, keeping primary‑care physicians engaged even after hospice enrollment. Hospices must therefore invest in data analytics, joint care plans and interoperable electronic health records to meet the heightened accountability demanded by risk‑bearing entities.

Strategically, hospices should view payvider collaborations as an opportunity to differentiate through integrated services rather than a threat. By positioning themselves as essential partners in a payer’s value‑based network, they can secure steadier revenue streams and gain access to broader patient populations. Building joint ventures or shared‑savings agreements can further align goals and mitigate financial exposure. As more insurers adopt the payvider model, the market will likely reward hospices that demonstrate measurable improvements in end‑of‑life quality, thereby reinforcing the nonprofit mission while sustaining growth.